High Sugar Intake and Development of Skeletal Muscle Insulin Resistance and Inflammation in Mice: A Protective Role for PPAR-δ Agonism

Peroxisome Proliferator Activated Receptor (PPAR)-δ agonists may serve for treating metabolic diseases. However, the effects of PPAR-δ agonism within the skeletal muscle, which plays a key role in whole-body glucose metabolism, remain unclear. This study aimed to investigate the signaling pathways a...

Full description

Bibliographic Details
Published in:	Mediators of Inflammation
Main Authors:	Elisa Benetti, Raffaella Mastrocola, Mara Rogazzo, Fausto Chiazza, Manuela Aragno, Roberto Fantozzi, Massimo Collino, Marco A. Minetto
Format:	Article
Language:	English
Published:	Wiley 2013-01-01
Online Access:	http://dx.doi.org/10.1155/2013/509502

Similar Items

High-fructose intake as risk factor for neurodegeneration: Key role for carboxy methyllysine accumulation in mice hippocampal neurons
by: Raffaella Mastrocola, et al.
Published: (2016-05-01)

Effects of vitamin D on insulin resistance and myosteatosis in diet-induced obese mice.
by: Elisa Benetti, et al.
Published: (2018-01-01)

Muscle-Specific PPARβ/δ Agonism May Provide Synergistic Benefits with Life Style Modifications
by: Adnan Erol
Published: (2007-01-01)

The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders
by: Elisa Benetti, et al.
Published: (2013-01-01)

Review of the Structural and Dynamic Mechanisms of PPARγ Partial Agonism
by: Alice J. Kroker, et al.
Published: (2015-01-01)

Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis.
by: Stefania Cannito, et al.
Published: (2017-01-01)

Pharmacological preconditioning with erythropoietin attenuates the organ injury and dysfunction induced in a rat model of hemorrhagic shock
by: Kiran K. Nandra, et al.
Published: (2013-05-01)

Baricitinib counteracts metaflammation, thus protecting against diet-induced metabolic abnormalities in mice
by: Debora Collotta, et al.
Published: (2020-09-01)

Dual PPAR α/γ Agonism Normalizes Lipoprotein Profile of Renal Dyslipidemia
by: O. Samuelsson, et al.
Published: (2013-01-01)

NO-Donating NSAIDs, PPARδ, and Cancer: Does PPARδ Contribute to Colon Carcinogenesis?
by: Gerardo G. Mackenzie, et al.
Published: (2008-01-01)

PPAR-δ in Vascular Pathophysiology
by: Nanping Wang
Published: (2008-01-01)

IL-15 Mediates Mitochondrial Activity through a PPARδ-Dependent-PPARα-Independent Mechanism in Skeletal Muscle Cells
by: Shantaé M. Thornton, et al.
Published: (2016-01-01)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
by: Robert I. Glazer, et al.
Published: (2008-01-01)

Conditional Expression of Human PPARδ and a Dominant Negative Variant of hPPARδ In Vivo
by: Larry G. Higgins, et al.
Published: (2012-01-01)

METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARδ-dependent pathways in skeletal muscle of mice
by: Tae Woo Jung, et al.
Published: (2018-09-01)

PPARβ/δ Agonism with GW501516 Increases Myotube PGC-1α Content and Reduces BCAA Media Content Independent of Changes in BCAA Catabolic Enzyme Expression
by: Caroline N. Rivera, et al.
Published: (2023-01-01)

PPARβ/δ upregulates the insulin receptor β subunit in skeletal muscle by reducing lysosomal activity and EphB4 levels
by: Jue-Rui Wang, et al.
Published: (2024-12-01)

PPARδ Attenuates Alcohol-Mediated Insulin Resistance by Enhancing Fatty Acid-Induced Mitochondrial Uncoupling and Antioxidant Defense in Skeletal Muscle
by: Jin-Ho Koh, et al.
Published: (2020-07-01)

Structure-based virtual screening and discovery of New PPARδ/γ dual agonist and PPARδ and γ agonists.
by: Vinicius G Maltarollo, et al.
Published: (2015-01-01)

Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data.
by: Giovanni Sansoè, et al.
Published: (2016-01-01)

Molecular mechanism of agonism and inverse agonism in ghrelin receptor
by: Jiao Qin, et al.
Published: (2022-01-01)

Inhibition of doxorubicin-induced senescence by PPARδ activation agonists in cardiac muscle cells: cooperation between PPARδ and Bcl6.
by: Paola Altieri, et al.
Published: (2012-01-01)

Regulation of Cell Proliferation and Differentiation by PPARβ/δ
by: Rolf Müller, et al.
Published: (2008-01-01)

Skin-targeted inhibition of PPAR β/δ by selective antagonists to treat PPAR β/δ-mediated psoriasis-like skin disease in vivo.
by: Katrin Hack, et al.
Published: (2012-01-01)

PPARα Is Required for PPARδ Action in Regulation of Body Weight and Hepatic Steatosis in Mice
by: Wojciech G. Garbacz, et al.
Published: (2015-01-01)

PPARγ Agonism Modulates Synovial Macrophage and Cartilage Responses in an Equine Model of Synovial Inflammation—Implications for Joint Therapy
by: Slàine F. Chaimbeul, et al.
Published: (2025-09-01)

Slow Metabolism–Driven Amplification of Hepatic PPARγ Agonism Mediates Benzbromarone‐Induced Obesity‐Specific Liver Injury
by: Guanting Li, et al.
Published: (2025-01-01)

Divergent Mechanisms for PPARγ Agonism in Ameliorating Aging-Related Versus Cranial Irradiation-Induced Context Discrimination Deficits
by: Ibdanelo Cortez, et al.
Published: (2019-03-01)

Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia
by: Marcela Doktorova, et al.
Published: (2017-04-01)

PPARα and PPARβ/δ are negatively correlated with proinflammatory markers in leukocytes of an obese pediatric population
by: Karina Vargas-Sánchez, et al.
Published: (2020-10-01)

A Role for PPARβ/δ in Tumor Stroma and Tumorigenesis
by: Rolf Müller, et al.
Published: (2008-01-01)

Artificial intelligence-rationalized balanced PPARα/γ dual agonism resets dysregulated macrophage processes in inflammatory bowel disease
by: Gajanan D. Katkar, et al.
Published: (2022-03-01)

Woman with agonal breathing
by: Chien‐Te Hsu, et al.
Published: (2023-06-01)

Markers of agonality in the discourse
by: Tambieva Fatima, et al.
Published: (2024-01-01)

Agonism and ethnography in Palestine
by: Anne Lene Stein
Published: (2025-06-01)

Metabolic Biomarkers in Adults with Type 2 Diabetes: The Role of PPAR-γ2 and PPAR-β/δ Polymorphisms
by: Sandra A. Reza-López, et al.
Published: (2023-12-01)

Evaluation of the Relationship between Peroxisome Proliferator Receptors (PPARα, PPARγ, and PPARδ) Expression and Carcinoembryonic Antigen (CEA) in Patients with Colorectal Cancer
by: Musa Yaghoubizadeh, et al.
Published: (2022-08-01)

Activation of Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) in Keratinocytes by Endogenous Fatty Acids
by: Bokai Zhu, et al.
Published: (2024-05-01)

PPARδ Activity in Cardiovascular Diseases: A Potential Pharmacological Target
by: Angela Tesse, et al.
Published: (2009-01-01)

PPARδ as a Metabolic Initiator of Mammary Neoplasia and Immune Tolerance
by: Robert I. Glazer
Published: (2016-01-01)